Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model

Muscle Nerve. 2016 Jan;53(1):127-33. doi: 10.1002/mus.24711. Epub 2015 Nov 21.

Abstract

Introduction: There are few reports of in vivo muscle strength measurements in animal models of ICU-acquired weakness (ICU-AW). In this study we investigated whether the Escherichia coli (E. coli) septic peritonitis mouse model may serve as an ICU-AW model using in vivo strength measurements and myosin/actin assays, and whether development of ICU-AW is age-dependent in this model.

Methods: Young and old mice were injected intraperitoneally with E. coli and treated with ceftriaxone. Forelimb grip strength was measured at multiple time points, and the myosin/actin ratio in muscle was determined.

Results: E. coli administration was not associated with grip strength decrease, neither in young nor in old mice. In old mice, the myosin/actin ratio was lower in E. coli mice at t = 48 h and higher at t = 72 h compared with controls.

Conclusions: This E. coli septic peritonitis mouse model did not induce decreased grip strength. In its current form, it seems unsuitable as a model for ICU-AW.

Keywords: animal model; critical illness myopathy; critical illness polyneuropathy; grip strength; intensive care unit-acquired weakness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Age Factors
  • Aging*
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Body Weight
  • Ceftriaxone / therapeutic use
  • Disease Models, Animal
  • Escherichia coli / pathogenicity*
  • Intensive Care Units*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle Weakness / etiology
  • Muscle Weakness / nursing*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Myosins / metabolism
  • Peritonitis / complications
  • Peritonitis / therapy*

Substances

  • Actins
  • Anti-Bacterial Agents
  • Ceftriaxone
  • Myosins